The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Final Evaluation Report of Capacity Building for Effective Implementation of UPC Core Course in NDDCB Preventive Staff, Sri Lanka
Report of the Universal Prevention Curriculum Core training conducted at NDDCB Auditorium on 7th, 8th, 9th, 10th and 11th February 2022.
People with tobacco use disorder exhibit more prefrontal activity during preparatory control but reduced anterior cingulate activity during reactive control
Abstract Reduced inhibitory control and a hypersensitivity to reward are key deficits in drug dependents; however, they tend to be studied in isolation. Here, we seek to understand the neural processes underlying control over reward and how...
Effects of family history of substance use disorder on reward processing in adolescents with and without attention-deficit/hyperactivity disorder
Abstract Patients with attention-deficit/hyperactivity disorder (ADHD) often develop early onset substance use disorder (SUD) and show poor treatment outcomes. Both disorders show similar reward-processing alterations, but it is unclear...
Sulphated dehydroepiandrosterone serum levels are reduced in women with alcohol use disorder and correlate negatively with craving: A sex-separated cross-sectional and longitudinal study
Abstract Previous studies have established a role of sex hormones in alcohol use disorder (AUD).Only few clinical investigations with low numbers of patients with AUD have focused on the sulphated form of dehydroepiandrosterone (DHEA-S)...
UTC-2 Training for Addiction Treatment Professionals of South Punjab, Pakistan.
“Training of Addiction Professionals for Pakistan Addiction Treatment Practitioners” February 22-25, 2022 (8 am to 6pm) Multan, Islamic Republic of Pakistan Description: Training Name: Training of Addiction Professionals for Pakistan...
Law Enforcement in Prevention Programming
An APSI Prevention Talk on how to appropriately engage law enforcement in the implementation of evidence-based prevention strategies, with specific reference to the prevention of substance use.
Study of SARS-CoV-2 seroprevalence in patients undergoing treatment for addictions in Madrid
Summary Background: Patients with addiction are a vulnerable group in which there is little data on the infection and severity of COVID-19. The objective of this study was to analyze the seroprevalence against SARS-CoV-2 in users in...
HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education
The Ohio Attorney General selected experts from a number of academic fields to the Scientific Committee on Opioid Prevention and Education (SCOPE) to help the State of Ohio in tackling the opioid crisis in the United States. The focus of...
The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
Early detection of Acquired Immune Deficiency Syndrome allows infected people to use prophylaxis against opportunistic infections and beginning immediate treatment for secondary complications. People who receive treatment benefit from...
The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya
Cannabis is the most widely used illegal substance in the world, with a global prevalence of 4% among people aged 15 to 64 years and a recent trend of growing use. Cannabis usage can have negative health consequences, such as impaired...